APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pediatric Vaccines Market Analysis and Forecast 2026-2032

Report ID 174023030227 December 2025207 pages

Choose your research edition.

Industry ResearchPediatric Vaccines Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Pediatric Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pediatric Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pediatric Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pediatric Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pediatric Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pediatric Vaccines include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pediatric Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pediatric Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Pediatric Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pediatric Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pediatric Vaccines sales, projected growth trends, production technology, application and end-user industry.

Pediatric Vaccines Segment by Company

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

S K Chemicals

Serum Institute of India

Sinovac Biotech

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Takeda Pharmaceutical

Janssen

Pediatric Vaccines Segment by Type

Meningococcal Diseases

Influenza

Hepatitis

Pneumococcal Diseases

Diphtheria

Others

Pediatric Vaccines Segment by Application

Infant

Newborn

Dolescent

Child

Pediatric Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pediatric Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pediatric Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Meningococcal Diseases Major Manufacturers Table 3. Influenza Major Manufacturers Table 4. Hepatitis Major Manufacturers Table 5. Pneumococcal Diseases Major Manufacturers Table 6. Diphtheria Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Pediatric Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Infant Major Manufacturers Table 10. Newborn Major Manufacturers Table 11. Dolescent Major Manufacturers Table 12. Child Major Manufacturers Table 13. Pediatric Vaccines Industry Trends Table 14. Pediatric Vaccines Industry Drivers Table 15. Pediatric Vaccines Industry Opportunities and Challenges Table 16. Pediatric Vaccines Industry Restraints Table 17. Global Pediatric Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pediatric Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Pediatric Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Pediatric Vaccines Revenue Market Share by Region (2021-2026) Table 21. Global Pediatric Vaccines Revenue Market Share by Region (2027-2032) Table 22. Global Pediatric Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Pediatric Vaccines Sales by Region (2021-2026) & (W Units) Table 24. Global Pediatric Vaccines Sales by Region (2027-2032) & (W Units) Table 25. Global Pediatric Vaccines Sales Market Share by Region (2021-2026) Table 26. Global Pediatric Vaccines Sales Market Share by Region (2027-2032) Table 27. Global Pediatric Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Pediatric Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Pediatric Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Pediatric Vaccines Sales Market Share by Manufacturers (2021-2026) Table 31. Global Pediatric Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Pediatric Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Pediatric Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Pediatric Vaccines Manufacturers, Product Type & Application Table 35. Global Pediatric Vaccines Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Pediatric Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Pediatric Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Pediatric Vaccines Revenue Market Share by Type (2021-2026) Table 42. Global Pediatric Vaccines Revenue Market Share by Type (2027-2032) Table 43. Global Pediatric Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 45. Global Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 46. Global Pediatric Vaccines Sales Market Share by Type (2021-2026) Table 47. Global Pediatric Vaccines Sales Market Share by Type (2027-2032) Table 48. Global Pediatric Vaccines Price by Type (2021-2026) & (US$/Unit) Table 49. Global Pediatric Vaccines Price by Type (2027-2032) & (US$/Unit) Table 50. Global Pediatric Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Pediatric Vaccines Revenue Market Share by Application (2021-2026) Table 54. Global Pediatric Vaccines Revenue Market Share by Application (2027-2032) Table 55. Global Pediatric Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 57. Global Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 58. Global Pediatric Vaccines Sales Market Share by Application (2021-2026) Table 59. Global Pediatric Vaccines Sales Market Share by Application (2027-2032) Table 60. Global Pediatric Vaccines Price by Application (2021-2026) & (US$/Unit) Table 61. Global Pediatric Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. Bavarian Nordic Company Information Table 63. Bavarian Nordic Business Overview Table 64. Bavarian Nordic Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Bavarian Nordic Pediatric Vaccines Product Portfolio Table 66. Bavarian Nordic Recent Development Table 67. Bharat Biotech Company Information Table 68. Bharat Biotech Business Overview Table 69. Bharat Biotech Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bharat Biotech Pediatric Vaccines Product Portfolio Table 71. Bharat Biotech Recent Development Table 72. Crucell Company Information Table 73. Crucell Business Overview Table 74. Crucell Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Crucell Pediatric Vaccines Product Portfolio Table 76. Crucell Recent Development Table 77. Dynavax Company Information Table 78. Dynavax Business Overview Table 79. Dynavax Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Dynavax Pediatric Vaccines Product Portfolio Table 81. Dynavax Recent Development Table 82. LG Life Sciences Company Information Table 83. LG Life Sciences Business Overview Table 84. LG Life Sciences Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. LG Life Sciences Pediatric Vaccines Product Portfolio Table 86. LG Life Sciences Recent Development Table 87. Lupin Company Information Table 88. Lupin Business Overview Table 89. Lupin Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lupin Pediatric Vaccines Product Portfolio Table 91. Lupin Recent Development Table 92. Mitsubishi Tanabe Pharma Company Information Table 93. Mitsubishi Tanabe Pharma Business Overview Table 94. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio Table 96. Mitsubishi Tanabe Pharma Recent Development Table 97. S K Chemicals Company Information Table 98. S K Chemicals Business Overview Table 99. S K Chemicals Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. S K Chemicals Pediatric Vaccines Product Portfolio Table 101. S K Chemicals Recent Development Table 102. Serum Institute of India Company Information Table 103. Serum Institute of India Business Overview Table 104. Serum Institute of India Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Serum Institute of India Pediatric Vaccines Product Portfolio Table 106. Serum Institute of India Recent Development Table 107. Sinovac Biotech Company Information Table 108. Sinovac Biotech Business Overview Table 109. Sinovac Biotech Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sinovac Biotech Pediatric Vaccines Product Portfolio Table 111. Sinovac Biotech Recent Development Table 112. AstraZeneca Company Information Table 113. AstraZeneca Business Overview Table 114. AstraZeneca Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. AstraZeneca Pediatric Vaccines Product Portfolio Table 116. AstraZeneca Recent Development Table 117. Baxter Company Information Table 118. Baxter Business Overview Table 119. Baxter Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Baxter Pediatric Vaccines Product Portfolio Table 121. Baxter Recent Development Table 122. GlaxoSmithKline Company Information Table 123. GlaxoSmithKline Business Overview Table 124. GlaxoSmithKline Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GlaxoSmithKline Pediatric Vaccines Product Portfolio Table 126. GlaxoSmithKline Recent Development Table 127. Pfizer Company Information Table 128. Pfizer Business Overview Table 129. Pfizer Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Pfizer Pediatric Vaccines Product Portfolio Table 131. Pfizer Recent Development Table 132. Merck Company Information Table 133. Merck Business Overview Table 134. Merck Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Merck Pediatric Vaccines Product Portfolio Table 136. Merck Recent Development Table 137. Novartis Company Information Table 138. Novartis Business Overview Table 139. Novartis Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Novartis Pediatric Vaccines Product Portfolio Table 141. Novartis Recent Development Table 142. Sanofi Company Information Table 143. Sanofi Business Overview Table 144. Sanofi Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Sanofi Pediatric Vaccines Product Portfolio Table 146. Sanofi Recent Development Table 147. Shenzhen Kangtai Biological Products Company Information Table 148. Shenzhen Kangtai Biological Products Business Overview Table 149. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio Table 151. Shenzhen Kangtai Biological Products Recent Development Table 152. Takeda Pharmaceutical Company Information Table 153. Takeda Pharmaceutical Business Overview Table 154. Takeda Pharmaceutical Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Takeda Pharmaceutical Pediatric Vaccines Product Portfolio Table 156. Takeda Pharmaceutical Recent Development Table 157. Janssen Company Information Table 158. Janssen Business Overview Table 159. Janssen Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Janssen Pediatric Vaccines Product Portfolio Table 161. Janssen Recent Development Table 162. North America Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 163. North America Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 164. North America Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 165. North America Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 166. North America Pediatric Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 167. North America Pediatric Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 168. North America Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 169. North America Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 170. North America Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 171. North America Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 172. North America Pediatric Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 173. North America Pediatric Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 174. North America Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. North America Pediatric Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. North America Pediatric Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. North America Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 178. North America Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 179. North America Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 180. North America Pediatric Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 181. North America Pediatric Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 182. United States Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 183. Canada Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Mexico Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Europe Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 186. Europe Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 187. Europe Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 188. Europe Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 189. Europe Pediatric Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 190. Europe Pediatric Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 191. Europe Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 192. Europe Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 193. Europe Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 194. Europe Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 195. Europe Pediatric Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 196. Europe Pediatric Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 197. Europe Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. Europe Pediatric Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. Europe Pediatric Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. Europe Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 201. Europe Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 202. Europe Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 203. Europe Pediatric Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 204. Europe Pediatric Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Germany Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 206. France Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 207. U.K. Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 208. Italy Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Russia Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Spain Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Netherlands Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Switzerland Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Sweden Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Poland Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 215. China Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 216. China Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 217. China Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 218. China Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 219. China Pediatric Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 220. China Pediatric Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 221. China Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 222. China Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 223. China Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 224. China Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 225. China Pediatric Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 226. China Pediatric Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 227. Asia Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 228. Asia Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 229. Asia Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 230. Asia Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 231. Asia Pediatric Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 232. Asia Pediatric Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 233. Asia Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 234. Asia Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 235. Asia Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 236. Asia Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 237. Asia Pediatric Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 238. Asia Pediatric Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 239. Asia Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. Asia Pediatric Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. Asia Pediatric Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. Asia Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 243. Asia Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 244. Asia Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 245. Asia Pediatric Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 246. Asia Pediatric Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 247. Japan Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 248. South Korea Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 249. India Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 250. Australia Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Taiwan Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Southeast Asia Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 253. SAMEA Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 254. SAMEA Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 255. SAMEA Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 256. SAMEA Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 257. SAMEA Pediatric Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 258. SAMEA Pediatric Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 259. SAMEA Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 260. SAMEA Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 261. SAMEA Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 262. SAMEA Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 263. SAMEA Pediatric Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 264. SAMEA Pediatric Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 265. SAMEA Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. SAMEA Pediatric Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 267. SAMEA Pediatric Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 268. SAMEA Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 269. SAMEA Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 270. SAMEA Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 271. SAMEA Pediatric Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 272. SAMEA Pediatric Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 273. Brazil Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 274. Argentina Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 275. Chile Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 276. Colombia Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 277. Peru Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 278. Saudi Arabia Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 279. Israel Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 280. UAE Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 281. Turkey Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 282. Iran Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 283. Egypt Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Table 284. Key Raw Materials Table 285. Raw Materials Key Suppliers Table 286. Pediatric Vaccines Distributors List Table 287. Pediatric Vaccines Customers List Table 288. Research Programs/Design for This Report Table 289. Authors List of This Report Table 290. Secondary Sources Table 291. Primary Sources List of Figures Figure 1. Pediatric Vaccines Image Figure 2. Global Pediatric Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Meningococcal Diseases Image Figure 5. Influenza Image Figure 6. Hepatitis Image Figure 7. Pneumococcal Diseases Image Figure 8. Diphtheria Image Figure 9. Others Image Figure 10. Global Pediatric Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Pediatric Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 12. Infant Image Figure 13. Newborn Image Figure 14. Dolescent Image Figure 15. Child Image Figure 16. Global Pediatric Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Figure 18. Global Pediatric Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pediatric Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Pediatric Vaccines Revenue Market Share by Region (2021-2032) Figure 21. Global Pediatric Vaccines Sales (2021-2032) & (W Units) Figure 22. Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Pediatric Vaccines Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Pediatric Vaccines Sales YoY (2021-2032) & (W Units) Figure 25. Europe Pediatric Vaccines Sales YoY (2021-2032) & (W Units) Figure 26. China Pediatric Vaccines Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Pediatric Vaccines Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Pediatric Vaccines Sales YoY (2021-2032) & (W Units) Figure 29. Global Pediatric Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Pediatric Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Pediatric Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Pediatric Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Pediatric Vaccines Revenue Market Share by Type (2021-2032) Figure 35. Global Pediatric Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Pediatric Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Pediatric Vaccines Sales Market Share by Type (2021-2032) Figure 38. Global Pediatric Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Pediatric Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Pediatric Vaccines Revenue Market Share by Application (2021-2032) Figure 41. Global Pediatric Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Pediatric Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Pediatric Vaccines Sales Market Share by Application (2021-2032) Figure 44. North America Pediatric Vaccines Revenue Share by Type (2021-2032) Figure 45. North America Pediatric Vaccines Sales Share by Type (2021-2032) Figure 46. North America Pediatric Vaccines Revenue Share by Application (2021-2032) Figure 47. North America Pediatric Vaccines Sales Share by Application (2021-2032) Figure 48. North America Pediatric Vaccines Revenue Share by Country (2021-2032) Figure 49. North America Pediatric Vaccines Sales Share by Country (2021-2032) Figure 50. Europe Pediatric Vaccines Revenue Share by Type (2021-2032) Figure 51. Europe Pediatric Vaccines Sales Share by Type (2021-2032) Figure 52. Europe Pediatric Vaccines Revenue Share by Application (2021-2032) Figure 53. Europe Pediatric Vaccines Sales Share by Application (2021-2032) Figure 54. Europe Pediatric Vaccines Revenue Share by Country (2021-2032) Figure 55. Europe Pediatric Vaccines Sales Share by Country (2021-2032) Figure 56. China Pediatric Vaccines Revenue Share by Type (2021-2032) Figure 57. China Pediatric Vaccines Sales Share by Type (2021-2032) Figure 58. China Pediatric Vaccines Revenue Share by Application (2021-2032) Figure 59. China Pediatric Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Pediatric Vaccines Revenue Share by Type (2021-2032) Figure 61. Asia Pediatric Vaccines Sales Share by Type (2021-2032) Figure 62. Asia Pediatric Vaccines Revenue Share by Application (2021-2032) Figure 63. Asia Pediatric Vaccines Sales Share by Application (2021-2032) Figure 64. Asia Pediatric Vaccines Revenue Share by Country (2021-2032) Figure 65. Asia Pediatric Vaccines Sales Share by Country (2021-2032) Figure 66. SAMEA Pediatric Vaccines Revenue Share by Type (2021-2032) Figure 67. SAMEA Pediatric Vaccines Sales Share by Type (2021-2032) Figure 68. SAMEA Pediatric Vaccines Revenue Share by Application (2021-2032) Figure 69. SAMEA Pediatric Vaccines Sales Share by Application (2021-2032) Figure 70. SAMEA Pediatric Vaccines Revenue Share by Country (2021-2032) Figure 71. SAMEA Pediatric Vaccines Sales Share by Country (2021-2032) Figure 72. Pediatric Vaccines Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Pediatric Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Diseases
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Diphtheria
  • Others
Applications
  • Infant
  • Newborn
  • Dolescent
  • Child
Companies covered
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Takeda Pharmaceutical
  • Janssen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pediatric Vaccines Market by Type
  3. 1.2.1 Global Pediatric Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Meningococcal Diseases
  5. 1.2.3 Influenza
  6. 1.2.4 Hepatitis
  7. 1.2.5 Pneumococcal Diseases
  8. 1.2.6 Diphtheria
  9. 1.2.7 Others
  10. 1.3 Pediatric Vaccines Market by Application
  11. 1.3.1 Global Pediatric Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Infant
  13. 1.3.3 Newborn
  14. 1.3.4 Dolescent
  15. 1.3.5 Child
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Pediatric Vaccines Market Dynamics
  1. 2.1 Pediatric Vaccines Industry Trends
  2. 2.2 Pediatric Vaccines Industry Drivers
  3. 2.3 Pediatric Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pediatric Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pediatric Vaccines Revenue by Region
  3. 3.2.1 Global Pediatric Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pediatric Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Pediatric Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Pediatric Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pediatric Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pediatric Vaccines Sales by Region
  9. 3.4.1 Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pediatric Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Pediatric Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Pediatric Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pediatric Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Pediatric Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pediatric Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pediatric Vaccines Sales by Manufacturers
  6. 4.2.1 Global Pediatric Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pediatric Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pediatric Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pediatric Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pediatric Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pediatric Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pediatric Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Pediatric Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pediatric Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Pediatric Vaccines Tier 1, Tier 2, and Tier 3
5 Pediatric Vaccines Market by Type
  1. 5.1 Global Pediatric Vaccines Revenue by Type
  2. 5.1.1 Global Pediatric Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pediatric Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pediatric Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pediatric Vaccines Sales by Type
  6. 5.2.1 Global Pediatric Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pediatric Vaccines Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Pediatric Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pediatric Vaccines Price by Type
6 Pediatric Vaccines Market by Application
  1. 6.1 Global Pediatric Vaccines Revenue by Application
  2. 6.1.1 Global Pediatric Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pediatric Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pediatric Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pediatric Vaccines Sales by Application
  6. 6.2.1 Global Pediatric Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pediatric Vaccines Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Pediatric Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pediatric Vaccines Price by Application
7 Company Profiles
  1. 7.1 Bavarian Nordic
  2. 7.1.1 Bavarian Nordic Company Information
  3. 7.1.2 Bavarian Nordic Business Overview
  4. 7.1.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
  6. 7.1.5 Bavarian Nordic Recent Developments
  7. 7.2 Bharat Biotech
  8. 7.2.1 Bharat Biotech Company Information
  9. 7.2.2 Bharat Biotech Business Overview
  10. 7.2.3 Bharat Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
  12. 7.2.5 Bharat Biotech Recent Developments
  13. 7.3 Crucell
  14. 7.3.1 Crucell Company Information
  15. 7.3.2 Crucell Business Overview
  16. 7.3.3 Crucell Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Crucell Pediatric Vaccines Product Portfolio
  18. 7.3.5 Crucell Recent Developments
  19. 7.4 Dynavax
  20. 7.4.1 Dynavax Company Information
  21. 7.4.2 Dynavax Business Overview
  22. 7.4.3 Dynavax Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Dynavax Pediatric Vaccines Product Portfolio
  24. 7.4.5 Dynavax Recent Developments
  25. 7.5 LG Life Sciences
  26. 7.5.1 LG Life Sciences Company Information
  27. 7.5.2 LG Life Sciences Business Overview
  28. 7.5.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
  30. 7.5.5 LG Life Sciences Recent Developments
  31. 7.6 Lupin
  32. 7.6.1 Lupin Company Information
  33. 7.6.2 Lupin Business Overview
  34. 7.6.3 Lupin Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lupin Pediatric Vaccines Product Portfolio
  36. 7.6.5 Lupin Recent Developments
  37. 7.7 Mitsubishi Tanabe Pharma
  38. 7.7.1 Mitsubishi Tanabe Pharma Company Information
  39. 7.7.2 Mitsubishi Tanabe Pharma Business Overview
  40. 7.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
  42. 7.7.5 Mitsubishi Tanabe Pharma Recent Developments
  43. 7.8 S K Chemicals
  44. 7.8.1 S K Chemicals Company Information
  45. 7.8.2 S K Chemicals Business Overview
  46. 7.8.3 S K Chemicals Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
  48. 7.8.5 S K Chemicals Recent Developments
  49. 7.9 Serum Institute of India
  50. 7.9.1 Serum Institute of India Company Information
  51. 7.9.2 Serum Institute of India Business Overview
  52. 7.9.3 Serum Institute of India Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
  54. 7.9.5 Serum Institute of India Recent Developments
  55. 7.10 Sinovac Biotech
  56. 7.10.1 Sinovac Biotech Company Information
  57. 7.10.2 Sinovac Biotech Business Overview
  58. 7.10.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
  60. 7.10.5 Sinovac Biotech Recent Developments
  61. 7.11 AstraZeneca
  62. 7.11.1 AstraZeneca Company Information
  63. 7.11.2 AstraZeneca Business Overview
  64. 7.11.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
  66. 7.11.5 AstraZeneca Recent Developments
  67. 7.12 Baxter
  68. 7.12.1 Baxter Company Information
  69. 7.12.2 Baxter Business Overview
  70. 7.12.3 Baxter Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Baxter Pediatric Vaccines Product Portfolio
  72. 7.12.5 Baxter Recent Developments
  73. 7.13 GlaxoSmithKline
  74. 7.13.1 GlaxoSmithKline Company Information
  75. 7.13.2 GlaxoSmithKline Business Overview
  76. 7.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
  78. 7.13.5 GlaxoSmithKline Recent Developments
  79. 7.14 Pfizer
  80. 7.14.1 Pfizer Company Information
  81. 7.14.2 Pfizer Business Overview
  82. 7.14.3 Pfizer Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Pfizer Pediatric Vaccines Product Portfolio
  84. 7.14.5 Pfizer Recent Developments
  85. 7.15 Merck
  86. 7.15.1 Merck Company Information
  87. 7.15.2 Merck Business Overview
  88. 7.15.3 Merck Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Merck Pediatric Vaccines Product Portfolio
  90. 7.15.5 Merck Recent Developments
  91. 7.16 Novartis
  92. 7.16.1 Novartis Company Information
  93. 7.16.2 Novartis Business Overview
  94. 7.16.3 Novartis Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Novartis Pediatric Vaccines Product Portfolio
  96. 7.16.5 Novartis Recent Developments
  97. 7.17 Sanofi
  98. 7.17.1 Sanofi Company Information
  99. 7.17.2 Sanofi Business Overview
  100. 7.17.3 Sanofi Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Sanofi Pediatric Vaccines Product Portfolio
  102. 7.17.5 Sanofi Recent Developments
  103. 7.18 Shenzhen Kangtai Biological Products
  104. 7.18.1 Shenzhen Kangtai Biological Products Company Information
  105. 7.18.2 Shenzhen Kangtai Biological Products Business Overview
  106. 7.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
  108. 7.18.5 Shenzhen Kangtai Biological Products Recent Developments
  109. 7.19 Takeda Pharmaceutical
  110. 7.19.1 Takeda Pharmaceutical Company Information
  111. 7.19.2 Takeda Pharmaceutical Business Overview
  112. 7.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
  114. 7.19.5 Takeda Pharmaceutical Recent Developments
  115. 7.20 Janssen
  116. 7.20.1 Janssen Company Information
  117. 7.20.2 Janssen Business Overview
  118. 7.20.3 Janssen Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Janssen Pediatric Vaccines Product Portfolio
  120. 7.20.5 Janssen Recent Developments
8 North America
  1. 8.1 North America Pediatric Vaccines Market Size by Type
  2. 8.1.1 North America Pediatric Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Pediatric Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Pediatric Vaccines Price by Type (2021-2032)
  5. 8.2 North America Pediatric Vaccines Market Size by Application
  6. 8.2.1 North America Pediatric Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Pediatric Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Pediatric Vaccines Price by Application (2021-2032)
  9. 8.3 North America Pediatric Vaccines Market Size by Country
  10. 8.3.1 North America Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pediatric Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pediatric Vaccines Market Size by Type
  2. 9.1.1 Europe Pediatric Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pediatric Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Pediatric Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Pediatric Vaccines Market Size by Application
  6. 9.2.1 Europe Pediatric Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pediatric Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Pediatric Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Pediatric Vaccines Market Size by Country
  10. 9.3.1 Europe Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pediatric Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pediatric Vaccines Market Size by Type
  2. 10.1.1 China Pediatric Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Pediatric Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Pediatric Vaccines Price by Type (2021-2032)
  5. 10.2 China Pediatric Vaccines Market Size by Application
  6. 10.2.1 China Pediatric Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Pediatric Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Pediatric Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pediatric Vaccines Market Size by Type
  2. 11.1.1 Asia Pediatric Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pediatric Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Pediatric Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Pediatric Vaccines Market Size by Application
  6. 11.2.1 Asia Pediatric Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pediatric Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Pediatric Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Pediatric Vaccines Market Size by Country
  10. 11.3.1 Asia Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pediatric Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pediatric Vaccines Market Size by Type
  2. 12.1.1 SAMEA Pediatric Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pediatric Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pediatric Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Pediatric Vaccines Market Size by Application
  6. 12.2.1 SAMEA Pediatric Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pediatric Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pediatric Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Pediatric Vaccines Market Size by Country
  10. 12.3.1 SAMEA Pediatric Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pediatric Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pediatric Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pediatric Vaccines Value Chain Analysis
  2. 13.1.1 Pediatric Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pediatric Vaccines Production Mode & Process
  6. 13.2 Pediatric Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pediatric Vaccines Distributors
  9. 13.2.3 Pediatric Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst